Moderna CEO Says COVID-19 Vaccine Could Get Emergency Approval in December

As the top three COVID-19 vaccine projects get closer to the finish line, everybody is paying attention to when they might be available. Moderna recently said it expected an emergency use authorization (EUA) submission to the U.S. Food and Drug Administration (FDA) for its COVID-19 vaccine candidate in December. The company announced on October 14 that it had received written confirmation from the European Medicines Agency (EMA) that the vaccine was eligible for submission of an application for a European Union Marketing Authorization.